These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3511171)

  • 21. An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia.
    Myers DE; Uckun FM
    Leuk Lymphoma; 1995 Jun; 18(1-2):119-22. PubMed ID: 8580813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined therapeutic efficacy of the thymidylate synthase inhibitor ZD1694 (Tomudex) and the immunotoxin B43(anti-CD19)-PAP in a SCID mouse model of human B-lineage acute lymphoblastic leukemia.
    Ek O; Reaman GH; Crankshaw DL; Chelstrom LM; Myers DE; Uckun FM
    Leuk Lymphoma; 1998 Feb; 28(5-6):509-14. PubMed ID: 9613980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell-specific immunotoxin containing pokeweed antiviral protein.
    Uckun FM; Ramakrishnan S; Houston LL
    Cancer Res; 1985 Jan; 45(1):69-75. PubMed ID: 3871174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the intermolecular toxin-monoclonal antibody linkage on the in vivo stability, immunogenicity and anti-leukemic activity of B43 (anti-CD19) pokeweed antiviral protein immunotoxin.
    Uckun FM; Myers DE; Irvin JD; Kuebelbeck VM; Finnegan D; Chelstrom LM; Houston LL
    Leuk Lymphoma; 1993 Apr; 9(6):459-76. PubMed ID: 7687916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
    Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal human pluripotential and committed hematopoietic progenitors do not express the p24 antigen detected by monoclonal antibody BA-2: implications for immunotherapy of lymphocytic leukemia.
    Ash RC; Jansen J; Kersey JH; LeBien TW; Zanjani ED
    Blood; 1982 Dec; 60(6):1310-6. PubMed ID: 7139121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
    Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM
    Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells.
    Uckun FM; Gajl-Peczalska K; Meyers DE; Ramsay NC; Kersey JH; Colvin M; Vallera DA
    Blood; 1987 Jan; 69(1):361-6. PubMed ID: 3098325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase.
    Ek O; Gaynon P; Zeren T; Chelstrom LM; Myers DE; Uckun FM
    Leuk Lymphoma; 1998 Sep; 31(1-2):143-9. PubMed ID: 9720724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
    Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C
    Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
    Estrov Z; Freedman MH
    Cancer Res; 1988 Oct; 48(20):5901-7. PubMed ID: 3048651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinoside.
    Messinger Y; Yanishevski Y; Avramis VI; Ek O; Chelstrom LM; Gunther R; Myers DE; Irvin JD; Evans W; Uckun FM
    Clin Cancer Res; 1996 Sep; 2(9):1533-42. PubMed ID: 9816330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients.
    Uckun FM; Kersey JH; Gajl-Peczalska KJ; Heerema NA; Provisor AJ; Haag D; Gilchrist G; Song CW; Arthur DC; Roloff J
    J Clin Invest; 1987 Sep; 80(3):639-46. PubMed ID: 3497949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute lymphoblastic leukemia blast cells do not inhibit bone marrow hematopoietic progenitor colony formation.
    Estrov Z; Freedman MH
    Exp Hematol; 1991 Mar; 19(3):221-5. PubMed ID: 1995313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunotoxin for immunologic manipulation of marrow ex vivo in autologous transplantation for common acute lymphoblastic leukemia.
    Herrmann R; Pelham J; Meyer B; Davis R; Raphael C; Kraft N; Atkins R
    Transplant Proc; 1986 Apr; 18(2):278-80. PubMed ID: 2938314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.